Inicio>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Lomefloxacin (SC47111A)

Lomefloxacin (SC47111A)

Catalog No.GC33981

La lomefloxacina (SC47111A) (SC47111A) es un antibiÓtico de quinolona de amplio espectro, con actividad antimicrobiana.

Products are for research use only. Not for human use. We do not sell to patients.

Lomefloxacin (SC47111A) Chemical Structure

Cas No.: 98079-51-7

Tamaño Precio Disponibilidad Cantidad
100mg
50,00 $
Disponible
500mg
91,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Lomefloxacin(SC47111A) is a fluoroquinolone antibiotic.Target: AntibacterialLomefloxacin is a bactericidal fluoroquinolone agent with activity against a wide range of gram-negative and gram-positive organisms. The bactericidal action of lomefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited [1].

[1]. http://www.drugbank.ca/drugs/DB00978

Reseñas

Review for Lomefloxacin (SC47111A)

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lomefloxacin (SC47111A)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.